The Pharmaceutical Industry Heads Into Elon Musk’s Wood Chippernews2025-02-11T12:19:17+00:00February 11th, 2025|The New York Times|
Drug Company to Share Revenues With Indigenous People Who Donated Their Genesnews2025-01-07T12:03:05+00:00January 7th, 2025|The New York Times|
Pfizer Stopped Us From Getting Ozempic Decades Agonews2024-12-25T23:11:22+00:00December 25th, 2024|The New York Times|
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?news2024-11-13T10:01:57+00:00November 13th, 2024|The New York Times|
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countriesnews2024-10-02T23:12:20+00:00October 2nd, 2024|The New York Times|
Six Reasons Drug Prices Are So High in the U.S.news2024-01-17T18:53:05+00:00January 17th, 2024|The New York Times|
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Researchnews2023-12-25T10:00:53+00:00December 25th, 2023|The New York Times|
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Saysnews2023-09-14T18:20:16+00:00September 14th, 2023|The New York Times|
Why One Drug Company Held Back a Better Drugnews2023-09-07T10:00:12+00:00September 7th, 2023|The New York Times|
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapynews2023-07-22T18:26:55+00:00July 22nd, 2023|The New York Times|
